Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization - Wikidata - wikimedia - TriplyDB

Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization

Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization

http://www.wikidata.org/entity/Q27684578

about

bNAber: database of broadly neutralizing HIV antibodies Structural insights on the role of antibodies in HIV-1 vaccine and therapy Serology in the 21st century: the molecular-level analysis of the serum antibody repertoire Antibodies in HIV-1 vaccine development and therapy HIV broadly neutralizing antibody targets Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses Heavy Chain-Only IgG2b Llama Antibody Effects Near-Pan HIV-1 Neutralization by Recognizing a CD4-Induced Epitope That Includes Elements of Coreceptor- and CD4-Binding Sites Structural Basis for HIV-1 Neutralization by 2F5-Like Antibodies m66 and m66.6 Proteochemometric modeling of the antigen-antibody interaction: new fingerprints for antigen, antibody and epitope-paratope interaction Cross-Neutralizing Antibodies in HIV-1 Individuals Infected by Subtypes B, F1, C or the B/Bbr Variant in Relation to the Genetics and Biochemical Characteristics of the env Gene Systems serology for evaluation of HIV vaccine trials.Passive immunization against HIV/AIDS by antibody gene transfer.Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance Early development of broadly neutralizing antibodies in HIV-1-infected infants Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals.Transplanting supersites of HIV-1 vulnerability.Antibodies VRC01 and 10E8 neutralize HIV-1 with high breadth and potency even with Ig-framework regions substantially reverted to germline.Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models.Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface.Nucleotide insertions and deletions complement point mutations to massively expand the diversity created by somatic hypermutation of antibodies.Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits.High-density peptide arrays with combinatorial laser fusing.Structure and immune recognition of trimeric pre-fusion HIV-1 Env.Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individuals Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas.The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection Spatiotemporal hierarchy in antibody recognition against transmitted HIV-1 envelope glycoprotein during natural infection.HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans Antibodyomics: bioinformatics technologies for understanding B-cell immunity to HIV-1.Accurate predictions of population-level changes in sequence and structural properties of HIV-1 Env using a volatility-controlled diffusion model.

P2860

Q24567758-5228EFF9-C9AD-48EC-B0E4-09EDD0893A8E Q26829461-3FC1EF1B-8B67-464F-AE14-94FD78AA82A5 Q26997997-C845BA54-3E1F-4F05-965B-F8A313B1938A Q27011574-4512EA66-FDA1-4725-8E8C-ADE9A0A578B4 Q27026662-657AA6E6-4D18-4247-AFF6-111C38F5A2DB Q27319450-AACFF0C6-8C9D-4388-BA87-A0C4C0801CE4 Q27643993-FA4BE540-F9D8-407A-B58A-A15C0839EE93 Q27644383-4957B35A-2FD5-4393-93D7-5DCA7E197496 Q27644415-57D4523C-A59A-4DBC-962E-C6AA0AD65412 Q27644515-E8DE7737-D86E-4666-9451-8BB8B2BADEB9 Q27644544-F162E699-2B18-4CA3-B303-D75D4FB3A0F3 Q27679031-D733B390-C59B-4F47-8C7B-2FA9E82D97D0 Q27680872-F96D0A1C-6075-4DF6-B589-96B78D1621D7 Q28546634-54947E7C-328A-4EDC-B233-1212828E7598 Q28554907-2CEE1CB3-F15A-4311-9622-F875B9A1ECF6 Q30238729-91C4906C-40A6-46B3-85D3-372588F9DB47 Q30358434-B03D626F-5443-423F-B1F1-449556331D14 Q30644992-6C1F4876-B81A-4C65-BB83-1DCEFA68DBD0 Q33631104-40B2CDDF-0458-498D-86A1-B45BC3DA0386 Q33764917-C7F1B0FF-E2CE-489E-824A-FD1FFAD74582 Q33786447-1BE7226A-777B-456F-B99C-D8DF543CDEF1 Q33808304-21F16298-7D37-41B9-8F53-58A57B2FC7DA Q33854841-445303B9-8FDA-45F4-A936-02678C500D38 Q34075820-892D182B-A2D7-43C6-B0C8-4FA87852BA0F Q34133551-6874EF9F-7CC0-4FB8-AE65-14327B7480EF Q34455457-5122A9E5-454C-4846-A9A1-670C247E317B Q34473958-A85CC2C1-FBCB-49FA-9EF7-BCDFD42D60F1 Q34580389-4570B02C-827A-430F-B7B8-C7ADC8076EB9 Q34594513-AE2D32FA-95FC-479B-9BE0-2BA54156AD05 Q35111515-59B16E03-EB59-41FD-91AD-AD57B32F60DD Q35142291-FA27E3C2-2F60-4D43-BDFC-5C4D743E9D33 Q35164477-6B4F85BA-C179-4D01-AABA-20050179D3DB Q35677620-D5115F70-C5F0-4A89-9BB7-C361EB447DDE Q35686970-FF4C7D5D-F426-412E-90C6-FF9D875FE026 Q35925331-9D8FCA82-8F04-4718-9F8A-C5F24C220E17 Q35969973-15053873-42B9-4E7D-A746-4BB048687FD8 Q36239578-BB67F1B5-52E5-4BB4-8CEC-C13FC085CFB9 Q36252656-AA059A44-B897-4ABF-92A9-5090BE96A86A Q36263513-F51FEB0E-4A90-4045-AE11-85DF56ADC7D9 Q36337888-EC653CF0-4179-40C9-826D-2A71AC093F84

P2860

Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization

http://www.wikidata.org/entity/Q27684578

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Delineating antibody recogniti ...... f HIV-1 isolate neutralization

@ast

Delineating antibody recogniti ...... f HIV-1 isolate neutralization

@en

Delineating antibody recogniti ...... f HIV-1 isolate neutralization

@nl

type

label

Delineating antibody recogniti ...... f HIV-1 isolate neutralization

@ast

Delineating antibody recogniti ...... f HIV-1 isolate neutralization

@en

Delineating antibody recogniti ...... f HIV-1 isolate neutralization

@nl

prefLabel

Delineating antibody recogniti ...... f HIV-1 isolate neutralization

@ast

Delineating antibody recogniti ...... f HIV-1 isolate neutralization

@en

Delineating antibody recogniti ...... f HIV-1 isolate neutralization

@nl

P1433

Q27684578-0444B1F3-4BDB-479E-A8C1-8FBA0150645A

P1476

Q27684578-288AE2BC-EC72-4739-8FAB-2AC6F99F698A

P2093

Q27684578-033AD5F3-9EA7-4C05-A6EC-C1E6AE5D88F0

Q27684578-1B6D2E83-A1FB-4941-94A3-6A2BACFC633A

Q27684578-1D680E4A-B923-46D3-843B-976F2CD4C875

Q27684578-278DCBD6-E771-4307-8B9F-4D29F4CB2EEE

Q27684578-55B77CEF-1102-4723-B341-06FBE6517704

Q27684578-5FD14C39-34E4-4F4C-B948-A08A83D57166

Q27684578-8CB32BC2-C663-4215-B90A-0F79044932C2

Q27684578-90B37770-01FB-45DF-87A1-FA0858A6952E

Q27684578-9CFDF55B-BBF2-4DA4-BB2F-C97C44539848

Q27684578-B4305BC0-1776-471F-A1DC-C3DAED8AA244

P2860

Q27684578-01E9C8AE-C4FC-4494-AAC3-9A285E10F892

Q27684578-027947C2-63C8-4A5E-A721-78BBDFDB391A

Q27684578-0B350ADD-D903-4AF7-907D-1DDB065A23DB

Q27684578-14346DD7-B6DA-436F-AAD4-21CAAC371A48

Q27684578-2E7795BF-5EC7-4A0A-B690-B9BD0F3AA8D2

Q27684578-309F237D-5ADC-4C83-9BE7-720A3FD177A9

Q27684578-315756E5-EDC1-41CE-9697-0D175C5FB376

Q27684578-33FDA440-B40E-4506-A1A6-D3F22BDE0B29

Q27684578-346B752A-6700-4211-B21F-EB46CFB5C9B2

Q27684578-3A737EE0-2E98-444A-AE89-D1699A691FFF

P304

Q27684578-F297A47A-1F96-47B6-8511-B6FE9948A155

P31

Q27684578-C5CAF0AC-054A-4567-AAF2-D9C1D6E57F68

P3181

Q27684578-D8E40463-D180-4EAD-A04C-682BAE127FBE

P356

Q27684578-E221F932-2F69-43BE-8F8A-7A2A18FBFF77

P407

Q27684578-87251156-7CD7-4601-B62B-67475C6326EA

P433

Q27684578-207E135F-5A09-4A84-851F-4EE4591EAEBC

P478

Q27684578-36C07633-D31F-428C-BFAB-C6DAC4B2DA27

P50

Q27684578-488E2389-640E-46EE-9A8F-BADDCD0F0636

Q27684578-51969E3F-BBCC-4432-8089-895CDA07DAE5

Q27684578-90C70405-3FD0-45BE-92F0-2F6E81C42877

Q27684578-D26EF187-BBA5-436F-82FB-4E93875920FD

Q27684578-F580E120-1F87-4555-A100-FEC133CF27E6

Q27684578-F62C62CA-81C5-41CA-95C1-73502A9C491A

P577

Q27684578-8377F5F7-7E33-4E76-9E20-F3BAF9B5D5CF

P698

Q27684578-1B3AC48C-5022-441F-B5E8-438B7ABEC047

P921

Q27684578-C94CBBCF-14C0-4698-B186-6277CEA98507

P3181

P356

SCIENCE.1233989

P1433

P1476

Delineating antibody recogniti ...... f HIV-1 isolate neutralization

@en

P2093

Gilad Ofek

http://www.w3.org/2001/XMLSchema#string

Gwo-Yu Chuang

http://www.w3.org/2001/XMLSchema#string

Han R Altae-Tran

http://www.w3.org/2001/XMLSchema#string

Ivelin S Georgiev

http://www.w3.org/2001/XMLSchema#string

Krisha McKee

http://www.w3.org/2001/XMLSchema#string

Malcolm A Martin

http://www.w3.org/2001/XMLSchema#string

Marie Pancera

http://www.w3.org/2001/XMLSchema#string

Mark Connors

http://www.w3.org/2001/XMLSchema#string

Mark K Louder

http://www.w3.org/2001/XMLSchema#string

Martha Nason

http://www.w3.org/2001/XMLSchema#string

P2860

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

Increasing the potency and breadth of an HIV antibody by using structure-based rational design

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Structural definition of a conserved neutralization epitope on HIV-1 gp120

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids

Processing of X-ray diffraction data collected in oscillation mode

HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design

P304

751-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4434690

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCIENCE.1233989

http://www.w3.org/2001/XMLSchema#string

P407

P433

6133

http://www.w3.org/2001/XMLSchema#string

P478

340

http://www.w3.org/2001/XMLSchema#string

P50

Lawrence Shapiro

Stephanie Moquin

P577

2013-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23661761

http://www.w3.org/2001/XMLSchema#string

P921